Here are five things to know:
1. Jeanne Forneris will be the new vice president of strategy and general counsel.
2. She has been part of the executive team since 2012 and currently serves as vice president of business development and general counsel.
3. Bioventus wants to become the global leader in orthobiologics; Ms. Forneris is tasked with helping lead the company there.
4. She will continue to be in charge of all ethics and compliance functions at the company.
5. Ms. Forneris will continue to report to CEO Tony Bihl.
“Jeanne’s presence on the executive team has been invaluable for Bioventus and her new role will allow the company to enjoy greater benefit of her strategic insights,” said Mr. Bihl. “As Bioventus approaches its third anniversary we continue to strengthen and grow in all aspects of our business including senior leadership.”
More articles on orthopedic devices:
MEDTECH sells 3 ROSA surgical robots in Asia: 5 things to know
K2M, Mazor, Amedica & more—12 key notes
Mazor logs $5.2M net loss in Q1: 11 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
